Eric Schwartz Integra Lifesciences Holdings Corp (IART) insider trading activity

Eric Schwartz is EVP, Chief Legal Officer & Sec of INTEGRA LIFESCIENCES HOLDINGS CORP. Currently has a direct ownership of 63,581 shares of IART, which is worth approximately $1.46 Million. The most recent transaction as insider was on Mar 12, 2024, when has been sold 1,438 shares (Common Stock) at a price of $35.88 per share, resulting in proceeds of $51,595. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.6K

0% 3M change

30.83% 12M change

Total Value Held $1.46 Million

Eric Schwartz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 12 2024	SELL Payment of exercise price or tax liability	$51,595 $35.88 p/Share	1,438 Reduced 2.21%	63,581 Common Stock
Mar 11 2024	SELL Payment of exercise price or tax liability	$49,657 $36.22 p/Share	1,371 Reduced 2.72%	48,991 Common Stock
Mar 11 2024	BUY Grant, award, or other acquisition	-	16,028 Added 19.78%	65,019 Common Stock
Mar 10 2024	SELL Payment of exercise price or tax liability	$29,347 $36.73 p/Share	799 Reduced 1.56%	50,362 Common Stock
Feb 20 2024	BUY Grant, award, or other acquisition	-	2,564 Added 4.77%	51,161 Common Stock
Jun 01 2023	BUY Open market or private purchase	$100,029 $37.89 p/Share	2,640 Added 5.15%	48,597 Common Stock
Mar 13 2023	SELL Payment of exercise price or tax liability	$76,678 $57.61 p/Share	1,331 Reduced 2.81%	45,957 Common Stock
Mar 12 2023	SELL Payment of exercise price or tax liability	$61,857 $52.87 p/Share	1,170 Reduced 2.41%	47,288 Common Stock
Mar 11 2023	SELL Payment of exercise price or tax liability	$199,002 $52.87 p/Share	3,764 Reduced 7.21%	48,458 Common Stock
Mar 10 2023	BUY Grant, award, or other acquisition	-	5,070 Added 8.85%	52,222 Common Stock
Feb 13 2023	BUY Grant, award, or other acquisition	-	9,757 Added 17.14%	47,152 Common Stock
Mar 13 2022	SELL Payment of exercise price or tax liability	$186,801 $65.11 p/Share	2,869 Reduced 7.13%	37,395 Common Stock
Mar 12 2022	SELL Payment of exercise price or tax liability	$93,758 $65.11 p/Share	1,440 Reduced 3.45%	40,264 Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	-	9,792 Added 19.02%	41,704 Common Stock
Mar 01 2022	SELL Payment of exercise price or tax liability	$113,540 $66.32 p/Share	1,712 Reduced 5.09%	31,912 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	10,539 Added 23.86%	33,624 Common Stock
Dec 03 2021	SELL Payment of exercise price or tax liability	$151,334 $62.69 p/Share	2,414 Reduced 9.47%	23,085 Common Stock
Mar 13 2021	SELL Payment of exercise price or tax liability	$29,964 $68.1 p/Share	440 Reduced 1.7%	25,499 Common Stock
Mar 12 2021	BUY Grant, award, or other acquisition	-	2,411 Added 8.5%	25,939 Common Stock
Mar 02 2021	SELL Open market or private sale	$291,049 $69.1 p/Share	4,212 Reduced 15.18%	23,528 Common Stock
Mar 01 2021	SELL Payment of exercise price or tax liability	$115,879 $69.43 p/Share	1,669 Reduced 5.68%	27,740 Common Stock
Feb 25 2021	SELL Open market or private sale	$159,062 $69.52 p/Share	2,288 Reduced 7.22%	29,409 Common Stock
Dec 03 2020	SELL Payment of exercise price or tax liability	$83,204 $54.92 p/Share	1,515 Reduced 4.56%	31,697 Common Stock

Eric Schwartz

EVP, Chief Legal Officer & Sec

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IART shares.

Notify only if

Value

Insider Trading

Get notified when an Integra Lifesciences Holdings Corp insider buys or sells IART shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTEGRA LIFESCIENCES HOLDINGS CORP

Track Activities on IART

Account